| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |